Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Jan, Buter"'
Autor:
Saskia H. Hanemaaijer, Iris C. Kok, Rudolf S. N. Fehrmann, Bert van der Vegt, Jourik A. Gietema, Boudewijn E. C. Plaat, Marcel A. T. M. van Vugt, Marije R. Vergeer, C. René Leemans, Johannes A. Langendijk, Jens Voortman, Jan Buter, Sjoukje F. Oosting
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Chemoradiotherapy (CRT) including three cycles of cisplatin is considered the standard of care for locally advanced head and neck squamous cell carcinoma (LA-HNSCC). However, around one-third of the patients cannot complete cisplatin beca
Externí odkaz:
https://doaj.org/article/41c85e17066d44cbaa8705b2b5208976
Autor:
Reinout H. de Roest, Martijn van der Heijden, Frederik W.R. Wesseling, Emma J. de Ruiter, Martijn W. Heymans, Chris Terhaard, Marije R. Vergeer, Jan Buter, Lot A. Devriese, Jan Paul de Boer, Arash Navran, Ann Hoeben, Conchita Vens, Michiel van den Brekel, Ruud H. Brakenhoff, C. René Leemans, Frank Hoebers
Publikováno v:
de Roest, R H, van der Heijden, M, Wesseling, F W R, de Ruiter, E J, Heymans, M W, Terhaard, C, Vergeer, M R, Buter, J, Devriese, L A, de Boer, J P, Navran, A, Hoeben, A, Vens, C, van den Brekel, M, Brakenhoff, R H, Leemans, C R & Hoebers, F 2022, ' Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer ', Radiotherapy and Oncology, vol. 175, pp. 112-121 . https://doi.org/10.1016/j.radonc.2022.08.013
Radiotherapy and Oncology, 175, 112-121. Elsevier Ireland Ltd
Radiotherapy and oncology, 175, 112-121. Elsevier Ireland Ltd
Radiotherapy and Oncology, 175, 112-121. Elsevier Ireland Ltd
Radiotherapy and oncology, 175, 112-121. Elsevier Ireland Ltd
BACKGROUND: Definitive concomitant cisplatin-based chemoradiotherapy (CRT) is the current gold standard for most patients with advanced stage head and neck squamous cell carcinoma (HNSCC) of the pharynx and larynx. Since previous meta-analysis on CRT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a081d2140a35c3df4f3a4a0fb43a4001
https://doi.org/10.1016/j.radonc.2022.08.013
https://doi.org/10.1016/j.radonc.2022.08.013
Autor:
Pim J. French, Johan M. Kros, Peter A.E. Sillevis Smitt, René M. Vernhout, Bronno van der Holt, Aafke H. Honkoop, Jan Buter, Monique C.J. Hanse, Laurens V. Beerepoot, Annemiek Walenkamp, Hendrika M. Oosterkamp, Walter Taal, Maurice de Wit, Ya Gao, René Böttcher, Peter van der Spek, Andrew Stubbs, Hina Naz-Khan, Youri Hoogstrate, Martin J. van den Bent, Lale Erdem-Eraslan
Correlation in sample assignment between DASL and RNA-seq.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fc831e617536d936664cb59c46ad292
https://doi.org/10.1158/0008-5472.22408520
https://doi.org/10.1158/0008-5472.22408520
Autor:
Pim J. French, Johan M. Kros, Peter A.E. Sillevis Smitt, René M. Vernhout, Bronno van der Holt, Aafke H. Honkoop, Jan Buter, Monique C.J. Hanse, Laurens V. Beerepoot, Annemiek Walenkamp, Hendrika M. Oosterkamp, Walter Taal, Maurice de Wit, Ya Gao, René Böttcher, Peter van der Spek, Andrew Stubbs, Hina Naz-Khan, Youri Hoogstrate, Martin J. van den Bent, Lale Erdem-Eraslan
Performance of DASL and RNA-seq on RNA isolated from FFPE tissues, correlation with snap frozen samples.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e5047650f043ac96f143221d165b117
https://doi.org/10.1158/0008-5472.22408550.v1
https://doi.org/10.1158/0008-5472.22408550.v1
Autor:
Pim J. French, Johan M. Kros, Peter A.E. Sillevis Smitt, René M. Vernhout, Bronno van der Holt, Aafke H. Honkoop, Jan Buter, Monique C.J. Hanse, Laurens V. Beerepoot, Annemiek Walenkamp, Hendrika M. Oosterkamp, Walter Taal, Maurice de Wit, Ya Gao, René Böttcher, Peter van der Spek, Andrew Stubbs, Hina Naz-Khan, Youri Hoogstrate, Martin J. van den Bent, Lale Erdem-Eraslan
The results from the randomized phase II BELOB trial provided evidence for a potential benefit of bevacizumab (beva), a humanized monoclonal antibody against circulating VEGF-A, when added to CCNU chemotherapy in patients with recurrent glioblastoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a25cac1b80eba75c11040b651d6e1271
https://doi.org/10.1158/0008-5472.c.6507551.v1
https://doi.org/10.1158/0008-5472.c.6507551.v1
Autor:
Pim J. French, Johan M. Kros, Peter A.E. Sillevis Smitt, René M. Vernhout, Bronno van der Holt, Aafke H. Honkoop, Jan Buter, Monique C.J. Hanse, Laurens V. Beerepoot, Annemiek Walenkamp, Hendrika M. Oosterkamp, Walter Taal, Maurice de Wit, Ya Gao, René Böttcher, Peter van der Spek, Andrew Stubbs, Hina Naz-Khan, Youri Hoogstrate, Martin J. van den Bent, Lale Erdem-Eraslan
Legends for Supplementary Figures S1-S13.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f1c44f2f9184d5d626b2b8a51d54fdd
https://doi.org/10.1158/0008-5472.22408571.v1
https://doi.org/10.1158/0008-5472.22408571.v1
Autor:
Renske Gahrmann, Marion Smits, René Michel Vernhout, Walter Taal, Giorgios Kapsas, Jan Cees de Groot, Monique Hanse, Maaike Vos, Laurens Victor Beerepoot, Jan Buter, Zwenneke Hendrieke Flach, Bronno van der Holt, Martin van den Bent
Publikováno v:
Gahrmann, R, Smits, M, Vernhout, R M, Taal, W, Kapsas, G, de Groot, J C, Hanse, M, Vos, M, Beerepoot, L V, Buter, J, Flach, Z H, van der Holt, B & van den Bent, M 2022, ' The impact of different volumetric thresholds to determine progressive disease in patients with recurrent glioblastoma treated with bevacizumab ', Neuro-oncology advances, vol. 4, no. 1, vdac032 . https://doi.org/10.1093/noajnl/vdac032
Neuro-Oncology Advances, 4(1):vdac032. Oxford University Press
Neuro-oncology advances, 4(1):vdac032. Oxford University Press
Neuro-oncology advances, 4(1):vdac032
Neuro-Oncology Advances, 4(1):vdac032. Oxford University Press
Neuro-oncology advances, 4(1):vdac032. Oxford University Press
Neuro-oncology advances, 4(1):vdac032
Background The optimal volumetric threshold for determining progressive disease (PD) in recurrent glioblastoma is yet to be determined. We investigated a range of thresholds in association with overall survival (OS). Methods First recurrent glioblast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b0f793e0e28d276a5980a90eead8efa
https://doi.org/10.1093/noajnl/vdac032
https://doi.org/10.1093/noajnl/vdac032
Autor:
Youri Hoogstrate, Santoesha Ghisai, Kaspar Draaisma, Vincent Bours, Jan Buter, Isabelle vanden Bempt, Marica Eoli, Enrico Franceschi, Jean-Sebastien Frenel, Thierry Gorlia, Monique Hanse, Ann Hoeben, Melissa Kerkhof, Johan Kros, Sieger Leenstra, Guiseppe Lombardi, Slávka Lukacova, Pierre Robe, Juan M. Sepulveda, Walter Taal, Martin Taphoorn, Annemiek M.E. Walenkamp, Colin Watts, Michael Weller, Filip Y.F. de Vos, Martin van den Bent, Pim French
Publikováno v:
WFNOS 2022 Abstract Book.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a21ef110a7c59f388375c8ccc9523928
https://doi.org/10.14791/btrt.2022.10.f-1098
https://doi.org/10.14791/btrt.2022.10.f-1098
Autor:
Barbara Burtness, Kevin J Harrington, Richard Greil, Denis Soulières, Makoto Tahara, Gilberto de Castro, Amanda Psyrri, Neus Basté, Prakash Neupane, Åse Bratland, Thorsten Fuereder, Brett G M Hughes, Ricard Mesía, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Ruey-Long Hong, René González Mendoza, Ananya Roy, Yayan Zhang, Burak Gumuscu, Jonathan D Cheng, Fan Jin, Danny Rischin, Guillermo Lerzo, Marcelo Tatangelo, Mirta Varela, Juan Jose Zarba, Michael Boyer, Hui Gan, Bo Gao, Brett Hughes, Girish Mallesara, Anne Taylor, Martin Burian, Carlos Henrique Barrios, Dalvaro Oliveira de Castro Junior, Gilberto Castro, Fabio Andre Franke, Gustavo Girotto, Iane Pinto Figueiredo Lima, Ulisses Ribaldo Nicolau, Gustavo Dix Junqueira Pinto, Lucas Santos, Ana-Paula Victorino, Neil Chua, Felix Couture, Richard Gregg, Aaron Hansen, John Hilton, Joy McCarthy, Denis Soulieres, Rodrigo Ascui, Pablo Gonzalez, Luis Villanueva, Marco Torregroza, Angela Zambrano, Petra Holeckova, Zdenek Kral, Bohuslav Melichar, Jana Prausova, Milan Vosmik, Maria Andersen, Niels Gyldenkerne, Hannes Jurgens, Kadri Putnik, Petri Reinikainen, Viktor Gruenwald, Simon Laban, Gerasimos Aravantinos, Ioannis Boukovinas, Vassilis Georgoulias, Dora Kwong, Yousuf Al-Farhat, Tibor Csoszi, Jozsef Erfan, Geza Horvai, Laszlo Landherr, Eva Remenar, Agnes Ruzsa, Judit Szota, Salem Billan, Iris Gluck, Orit Gutfeld, Aron Popovtzer, Marco Benasso, Simona Bui, Vittorio Ferrari, Lisa Licitra, Franco Nole, Takashi Fujii, Yasushi Fujimoto, Nobuhiro Hanai, Hiroki Hara, Koji Matsumoto, Kenji Mitsugi, Nobuya Monden, Masahiro Nakayama, Kenji Okami, Nobuhiko Oridate, Kiyoto Shiga, Yasushi Shimizu, Masashi Sugasawa, Masanobu Takahashi, Shunji Takahashi, Kaoru Tanaka, Tsutomu Ueda, Hironori Yamaguchi, Tomoko Yamazaki, Ryuji Yasumatsu, Tomoya Yokota, Tomokazu Yoshizaki, Iveta Kudaba, Zinaida Stara, Soon Keat Cheah, Jose Aguilar Ponce, Rene Gonzalez Mendoza, Carlos Hernandez Hernandez, Francisco Medina Soto, Jan Buter, Ann Hoeben, S. Oosting, Karijn Suijkerbuijk, Aase Bratland, Marianne Brydoey, Renzo Alvarez, Luis Mas, Priscilla Caguioa, John Querol, Eugenio Emmanuel Regala, Maria Belen Tamayo, Ellie May Villegas, Andrzej Kawecki, Andrey Karpenko, Arkadiy Klochikhin, Alexey Smolin, Oleg Zarubenkov, Boon Cher Goh, Graham Cohen, Johanna du Toit, Christa Jordaan, Gregory Landers, Paul Ruff, Waldemar Szpak, Neonyana Tabane, Irene Brana, Lara Iglesias Docampo, Javier Lavernia, Ricard Mesia, Edvard Abel, Valentina Muratidu, Niels Nielsen, Valerie Cristina, Sacha Rothschild, Hung-Ming Wang, Muh-Hwa Yang, Su-Peng Yeh, Chia-Jui Yen, Nopadol Soparattanapaisarn, Virote Sriuranpong, Sercan Aksoy, Irfan Cicin, Meltem Ekenel, Hakan Harputluoglu, Ozgur Ozyilkan, Kevin Harrington, Sanjiv Agarwala, Haythem Ali, Robert Alter, Daniel Anderson, Justine Bruce, Nicholas Campbell, Miguel Conde, John Deeken, William Edenfield, Lawrence Feldman, Elizabeth Gaughan, Basem Goueli, Balazs Halmos, Upendra Hegde, Brian Hunis, Robert Jotte, Anand Karnad, Saad Khan, Noel Laudi, Douglas Laux, Danko Martincic, Steven McCune, Dean McGaughey, Krzysztof Misiukiewicz, Deborah Mulford, Eric Nadler, Johannes Nunnink, James Ohr, Meaghan O'Malley, Brian Patson, Doru Paul, Elizabeta Popa, Steven Powell, Rebecca Redman, Vincent Rella, Chaio Rocha Lima, Abirami Sivapiragasam, Yungpo Su, Ammar Sukari, Stuart Wong, Emrullah Yilmaz, Jeffrey Yorio
Publikováno v:
The Lancet, 394(10212), 1915-1928. ELSEVIER SCIENCE INC
BACKGROUND: Pembrolizumab is active in head and neck squamous cell carcinoma (HNSCC), with programmed cell death ligand 1 (PD-L1) expression associated with improved response.METHODS: KEYNOTE-048 was a randomised, phase 3 study of participants with u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b09cca112b6c7ad9036b0332984d6f1
https://research.rug.nl/en/publications/20397cd6-a956-4739-9a91-2e8cc9ca248f
https://research.rug.nl/en/publications/20397cd6-a956-4739-9a91-2e8cc9ca248f
Autor:
Jelle J Lindenberg, Dinja Oosterhoff, Claudia C Sombroek, Sinéad M Lougheed, Erik Hooijberg, Anita G M Stam, Saskia J A M Santegoets, Henk J Tijssen, Jan Buter, Herbert M Pinedo, Alfons J M van den Eertwegh, Rik J Scheper, Hans J P M Koenen, Rieneke van de Ven, Tanja D de Gruijl
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e70237 (2013)
In cancer patients pervasive systemic suppression of Dendritic Cell (DC) differentiation and maturation can hinder vaccination efficacy. In this study we have extensively characterized migratory DC subsets from human skin and studied how their migrat
Externí odkaz:
https://doaj.org/article/e9d9d82e42794b9fa4ba094021b7285f